Factors Predicting Trastuzumab-related Cardiotoxicity in a Real-world Population of Women with HER2+ Breast Cancer

DAVID NAUMANN; VICTORIA RUSIUS; CHIARA MARGIOTTA; ALAN NEVILL; AMTUL CARMICHAEL; DANIEL REA; MARTIN SINTLER

Research ArticleClinical Studies

Factors Predicting Trastuzumab-related Cardiotoxicity in a Real-world Population of Women with HER2⁺ Breast Cancer

DAVID NAUMANN, VICTORIA RUSIUS, CHIARA MARGIOTTA, ALAN NEVILL, AMTUL CARMICHAEL, DANIEL REA and MARTIN SINTLER

Anticancer Research April 2013, 33 (4) 1717-1720;

DAVID NAUMANN

1Sandwell and West Birmingham Hospitals NHS Trust, Lyndon, West Bromwich, Westmidlands, U.K.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: david.naumann{at}nhs.net

VICTORIA RUSIUS

2The Dudley Group NHS Foundation Trust, Dudley, Westmidlands, U.K.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

CHIARA MARGIOTTA

3University Hospital Birmingham NHS Foundation Trust, Birmingham, U.K.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

ALAN NEVILL

4School of Sport, Performing Arts and Leisure, University of Wolverhampton, Walsall, U.K.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

AMTUL CARMICHAEL

2The Dudley Group NHS Foundation Trust, Dudley, Westmidlands, U.K.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DANIEL REA

3University Hospital Birmingham NHS Foundation Trust, Birmingham, U.K.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MARTIN SINTLER

1Sandwell and West Birmingham Hospitals NHS Trust, Lyndon, West Bromwich, Westmidlands, U.K.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Cardiotoxicity subgroup: Time to first event and age of patient.

Tables

Figures

PreviousNext

In this issue

Anticancer Research

Vol. 33, Issue 4

April 2013

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Factors Predicting Trastuzumab-related Cardiotoxicity in a Real-world Population of Women with HER2+ Breast Cancer

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 1 + 7 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Factors Predicting Trastuzumab-related Cardiotoxicity in a Real-world Population of Women with HER2⁺ Breast Cancer

DAVID NAUMANN, VICTORIA RUSIUS, CHIARA MARGIOTTA, ALAN NEVILL, AMTUL CARMICHAEL, DANIEL REA, MARTIN SINTLER

Anticancer Research Apr 2013, 33 (4) 1717-1720;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Factors Predicting Trastuzumab-related Cardiotoxicity in a Real-world Population of Women with HER2⁺ Breast Cancer

DAVID NAUMANN, VICTORIA RUSIUS, CHIARA MARGIOTTA, ALAN NEVILL, AMTUL CARMICHAEL, DANIEL REA, MARTIN SINTLER

Anticancer Research Apr 2013, 33 (4) 1717-1720;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Treatment-related acute toxicity with adjuvant systemic treatment among patients with HER2-positive early invasive breast cancer: a national population-based cohort study
Association of hospital and physician case volumes with cardiac monitoring and cardiotoxicity during adjuvant trastuzumab treatment for breast cancer: a retrospective cohort study
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction

Google Scholar

Keywords

trastuzumab
cardiotoxicity
breast cancer
HER2

Main menu

User menu

Search

Factors Predicting Trastuzumab-related Cardiotoxicity in a Real-world Population of Women with HER2⁺ Breast Cancer

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords